Home › Immunoblastic Lymphadenopathy › Illinois
Immunoblastic Lymphadenopathy clinical trials in Illinois
4 studies for Immunoblastic Lymphadenopathy are looking for participants at sites in Illinois.
Cities in Illinois
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
- North Western University Robert H. Lurie Comprehensive Cancer Center RHLCCC, Chicago
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06561048Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
- Northwestern University, Chicago
- University of Illinois, Chicago
- Northwestern Medicine Cancer Center Kishwaukee, DeKalb
- and 6 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT04803201A Registry for People With T-cell Lymphoma
- Northwestern Medicine (Data Collection), Chicago
RecruitingObservational study
All ages · All sexes · Updated May 20, 2026 · NCT05978141Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
- Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 22, 2025 · NCT04234048From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.